Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency Patients.

Bienvenu B, Cozon G, Mataix Y, Lachaud D, Alix A, Hoarau C, Antier D, Hachulla E, Brice S, Viallard JF, Tamisier S, Fauchais AL, Renon-Carron F, Clerson P, Fardini Y, Crave JC, Miossec P.

J Clin Immunol. 2018 May;38(4):503-512. doi: 10.1007/s10875-018-0507-x. Epub 2018 May 31.

2.

In-depth interviews of patients with primary immunodeficiency who have experienced pump and rapid push subcutaneous infusions of immunoglobulins reveal new insights on their preference and expectations.

Cozon GJN, Clerson P, Dokhan A, Fardini Y, Sala TP, Crave JC.

Patient Prefer Adherence. 2018 Mar 26;12:423-429. doi: 10.2147/PPA.S156983. eCollection 2018.

3.

A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?

Pasquet M, Pellier I, Aladjidi N, Auvrignon A, Cherin P, Clerson P, Cozon GJN, Jaussaud R, Bienvenu B, Hoarau C.

Patient Prefer Adherence. 2017 Jul 10;11:1171-1180. doi: 10.2147/PPA.S123363. eCollection 2017.

4.

Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial.

Viallard JF, Agape P, Barlogis V, Cozon G, Faure C, Fouyssac F, Gaud C, Gourin MP, Hamidou M, Hoarau C, Husseini F, Ojeda-Uribe M, Pavic M, Pellier I, Perlat A, Schleinitz N, Slama B.

BMC Immunol. 2016 Sep 29;17(1):34.

5.

Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".

Bienvenu B, Cozon G, Hoarau C, Pasquet M, Cherin P, Clerson P, Hachulla E, Crave JC, Delain JC, Jaussaud R.

Orphanet J Rare Dis. 2016 Jun 22;11(1):83. doi: 10.1186/s13023-016-0452-9.

6.

[Chronic fatigue syndrome: A new disorder?]

de Korwin JD, Chiche L, Banovic I, Ghali A, Delliaux S, Authier FJ, Cozon G, Hatron PY, Fornasieri I, Morinet F.

Rev Med Interne. 2016 Dec;37(12):811-819. doi: 10.1016/j.revmed.2016.05.003. Epub 2016 May 31. French.

PMID:
27260787
7.

[Iron deficiency and digestive disorders].

Cozon GJ.

Transfus Clin Biol. 2014 Nov;21(4-5):189-92. doi: 10.1016/j.tracli.2014.08.135. Epub 2014 Oct 2. Review. French.

PMID:
25282486
8.

Negativity of the basophil activation test in quinolone hypersensitivity: a breakthrough for provocation test decision-making.

Rouzaire P, Nosbaum A, Denis L, Bienvenu F, Bérard F, Cozon G, Bienvenu J.

Int Arch Allergy Immunol. 2012;157(3):299-302. doi: 10.1159/000328211. Epub 2011 Oct 31.

PMID:
22041525
9.

Detection and quantification of drug-specific T cells in penicillin allergy.

Rozieres A, Hennino A, Rodet K, Gutowski MC, Gunera-Saad N, Berard F, Cozon G, Bienvenu J, Nicolas JF.

Allergy. 2009 Apr;64(4):534-42. doi: 10.1111/j.1398-9995.2008.01674.x. Epub 2009 Jan 12.

PMID:
19154548
10.

Abnormal cellular reactivity to microbial antigens in patients with uveitis.

Cozon GJ, Mbitikon-Kobo FM, Fatoohi F, Spire M, Grange JD, Kodjikian L.

Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2526-30. doi: 10.1167/iovs.07-1454. Epub 2008 Mar 24.

PMID:
18362113
11.

Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.

Lefevre-Pettazzoni M, Bissery A, Wallon M, Cozon G, Peyron F, Rabilloud M.

Clin Vaccine Immunol. 2007 Mar;14(3):239-43. Epub 2007 Jan 3.

12.

Recurrent idiopathic thrombotic thrombocytopenic purpura: a role for vaccination in disease relapse?

Brodin-Sartorius A, Guebre-Egziabher F, Fouque D, Cozon G, Villar E, Laville M, Juillard L.

Am J Kidney Dis. 2006 Sep;48(3):e31-4.

PMID:
16931205
13.

Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.

Baril L, Dietemann J, Essevaz-Roulet M, Béniguel L, Coan P, Briles DE, Guy B, Cozon G.

Clin Exp Immunol. 2006 Aug;145(2):277-86.

14.

Staphylococcal enterotoxin-like toxins U2 and V, two new staphylococcal superantigens arising from recombination within the enterotoxin gene cluster.

Thomas DY, Jarraud S, Lemercier B, Cozon G, Echasserieau K, Etienne J, Gougeon ML, Lina G, Vandenesch F.

Infect Immun. 2006 Aug;74(8):4724-34. Erratum in: Infect Immun. 2007 Apr;75(4):2088.

15.

Systemic T cell response to Toxoplasma gondii antigen in patients with ocular toxoplasmosis.

Fatoohi F, Cozon GJ, Wallon M, Kodjikian L, Peyron F.

Jpn J Ophthalmol. 2006 Mar-Apr;50(2):103-10.

PMID:
16604384
16.

Heterogeneity in cellular and humoral immune responses against Toxoplasma gondii antigen in humans.

Fatoohi AF, Cozon GJ, Gonzalo P, Mayencon M, Greenland T, Picot S, Peyron F.

Clin Exp Immunol. 2004 Jun;136(3):535-41.

17.

Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro.

Gauduchon V, Cozon G, Vandenesch F, Genestier AL, Eyssade N, Peyrol S, Etienne J, Lina G.

J Infect Dis. 2004 Jan 15;189(2):346-53. Epub 2004 Jan 9.

PMID:
14722901
18.

Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts.

Fatoohi AF, Cozon GJ, Wallon M, Kahi S, Gay-Andrieu F, Greenland T, Peyron F.

Eur J Clin Microbiol Infect Dis. 2003 Mar;22(3):181-4. Epub 2003 Mar 4.

PMID:
12649716
19.

Progesterone fails to modulate Toxoplasma gondii replication in the RAW 264.7 murine macrophage cell line.

Gay-Andrieu F, Cozon GJ, Ferrandiz J, Peyron F.

Parasite Immunol. 2002 Apr;24(4):173-8.

20.

Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.

Fatoohi AF, Cozon GJ, Greenland T, Ferrandiz J, Bienvenu J, Picot S, Peyron F.

Clin Diagn Lab Immunol. 2002 May;9(3):704-7.

22.

Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children.

Wallon M, Cozon G, Ecochard R, Lewin P, Peyron F.

Eur J Pediatr. 2001 Sep;160(9):534-40.

PMID:
11585075
23.

Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients.

Soumelis V, Scott I, Gheyas F, Bouhour D, Cozon G, Cotte L, Huang L, Levy JA, Liu YJ.

Blood. 2001 Aug 15;98(4):906-12.

24.

Delayed-type hypersensitivity and chronic fatigue syndrome: the usefulness of assessing T-cell activation by flow cytometry--preliminary study.

Brunet JL, Liaudet AP, Later R, Peyramond D, Cozon GJ.

Allerg Immunol (Paris). 2001 Apr;33(4):166-72.

PMID:
11434196
25.

[Congenital toxoplasmosis. Transitory negative serology].

Jaisson-Hot I, Wallon M, al Kurdi M, Thulliez P, Kahi S, Cozon G, Peyron F.

Presse Med. 2001 Jun 9;30(20):1001-4. French.

PMID:
11433684
26.
27.

[Immunological mechanisms of fatigue in patients with multiple sclerosis].

Cozon GJ.

Rev Neurol (Paris). 2000 Nov;156(11):1042-3. French. No abstract available.

PMID:
11119061
28.

Detection of specific T lymphocytes in systemic abnormal delayed type hypersensitivity to Candida albicans.

Cozon GJ, Brunet JL, Peyramond D.

Inflamm Res. 2000 Apr;49 Suppl 1:S39-40. No abstract available.

PMID:
10864413
29.

Flow cytometric application of the Sabin and Feldman dye test in the diagnosis of toxoplasmosis.

Cozon GJ, Ferrandiz J, Thulliez P, Peyron F.

J Microbiol Methods. 1999 Oct;38(1-2):131-6.

PMID:
10520593
30.

Early detection of cellular immunity in congenitally Toxoplasma gondii-infected children.

Kahi S, Cozon GJ, Peyron F.

Pediatr Infect Dis J. 1999 Sep;18(9):846-7. No abstract available.

PMID:
10493362
31.

Detection of activated basophils using flow cytometry for diagnosis in atopic patients.

Cozon G, Ferrándiz J, Peyramond D, Brunet J.

Allergol Immunopathol (Madr). 1999 Jul-Aug;27(4):182-7.

PMID:
10486441
32.

A switch towards Th2 during serological rebound in children with congenital toxoplasmosis.

Kahi S, Cozon GJ, Pinon JM, Greenland T, Wallon M, Al Kurdi M, Ferrandiz J, Peyron F.

Clin Exp Immunol. 1999 Sep;117(3):524-8.

33.

[Evaluation of allergic-type reactions to antibiotics and rapid immunotherapy].

Brunet JL, Boibieux A, Biron F, Bouhour D, Cozon G, Sainte-Laudy J, Chidiac C, Peyramond D.

Pathol Biol (Paris). 1999 May;47(5):491-3. French.

PMID:
10418025
34.

Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever.

Jarraud S, Cozon G, Vandenesch F, Bes M, Etienne J, Lina G.

J Clin Microbiol. 1999 Aug;37(8):2446-9.

35.

Flow cytometric quantification of Toxoplasma gondii cellular infection and replication.

Gay-Andrieu F, Cozon GJ, Ferrandiz J, Kahi S, Peyron F.

J Parasitol. 1999 Jun;85(3):545-9.

PMID:
10386451
36.

A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans.

Kahi S, Cozon GJ, Greenland T, Wallon M, Gay-Andrieu F, Peyron F.

Clin Diagn Lab Immunol. 1998 Nov;5(6):745-8.

37.

[Rationale of infective risk of corticoids].

Cozon G.

Rev Pneumol Clin. 1998 Sep;54 Suppl 2:S22-4. French. No abstract available.

PMID:
9769963
38.

Circulating Toxoplasma gondii-specific antibody-secreting cells in patients with congenital toxoplasmosis.

Kahi S, Cozon GJ, Greenland T, Alkurdi M, Wallon M, Peyron F.

Clin Immunol Immunopathol. 1998 Oct;89(1):23-7.

PMID:
9756720
39.

Detection of staphylococcal superantigenic toxins by a CD69-specific cytofluorimetric assay measuring T-cell activation.

Lina G, Cozon G, Ferrandiz J, Greenland T, Vandenesch F, Etienne J.

J Clin Microbiol. 1998 Apr;36(4):1042-5.

40.

[Antibiotic tolerance. Clinical and biological evaluation methods. Preliminary study of 42 patients].

Brunet JL, Boibieux A, Biron F, Bouhour D, Chidiac C, Peyramond D, Cozon G, Sainte-Laudy J.

Allerg Immunol (Paris). 1998 Feb;30(2):49-51. French. No abstract available.

PMID:
9559062
41.

Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women.

Cozon GJ, Ferrandiz J, Nebhi H, Wallon M, Peyron F.

Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):32-6.

PMID:
9512179
42.

Identification of Encephalitozoon intestinalis in travelers with chronic diarrhea by specific PCR amplification.

Raynaud L, Delbac F, Broussolle V, Rabodonirina M, Girault V, Wallon M, Cozon G, Vivares CP, Peyron F.

J Clin Microbiol. 1998 Jan;36(1):37-40.

43.

[Diagnostic contribution of abnormal delayed-type hypersensitivity to Candida albicans. Characterization test by activation of cells sensitized to successive dilutions of Candida].

Brunet JL, Cozon G, Sainte-Laudy J, Boissel JP, Delair S, Peyramond D.

Allerg Immunol (Paris). 1997 Oct;29(8):233-8. French.

PMID:
9453734
44.

Absence of microchimerism in long-term tolerant living-donor kidney graft recipients.

Garnier JL, Daoud S, Favre-Victoire I, Cozon G, Boulez J, Dubernard JM, Betuel H, Touraine JL, Gebuhrer L.

Transplant Proc. 1996 Oct;28(5):2834. No abstract available.

PMID:
8908087
45.

[Activation of T-lymphocytes in Crohn disease and in ulcerative hemorrhagic rectocolitis. Therapeutic implications].

Voiglio E, Salle B, Lemaitre D, Cloix P, Bancel B, Cozon G.

Pathol Biol (Paris). 1996 Apr;44(4):287-92. Review. French.

PMID:
8763593
46.

Visna-maedi virus-induced expression of interleukin-8 gene in sheep alveolar cells following experimental in vitro and in vivo infection.

Legastelois I, Cordier G, Cozon G, Cadoré JL, Guiguen F, Greenland T, Mornex JF.

Res Virol. 1996 Mar-Jun;147(2-3):191-7.

PMID:
8901439
47.

[Toxoplasma gondii in the amniotic fluid. Comparison between 2 cell lines for culture isolation].

Wallon M, Sun X, Gandilhon F, Mojon M, Peyron F, Cozon G.

Presse Med. 1994 Sep 24;23(28):1312. French. No abstract available.

PMID:
7984532
48.

Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis.

Cozon G, Biron F, Jeannin M, Cannella D, Revillard JP.

J Infect Dis. 1994 Mar;169(3):696-9.

PMID:
8158056
49.

Lentivirus-induced interstitial lung disease: pulmonary pathology in sheep naturally infected by the visna-maedi virus.

Mornex JF, Lena P, Loire R, Cozon G, Greenland T, Guigen F, Jacquier MF, Cordier G.

Vet Res. 1994;25(5):478-88.

PMID:
7951350
50.

[Indolent mastocytosis and bronchial hyperreactivity. A case report].

Bayle JY, Arnouk H, de Perthuis D, Chouvet B, Germain-Pastene M, Cozon G, Béjui-Thivollet F, Pérol M, Sanson C, Guérin JC.

Rev Mal Respir. 1994;11(5):503-6. French.

PMID:
7816994

Supplemental Content

Support Center